Skip to main content
Top
Published in: Rheumatology International 11/2011

01-11-2011 | Original Article

Hearing organ disorders in patients with systemic sclerosis

Authors: Katarzyna Maciaszczyk, Elżbieta Waszczykowska, Anna Pajor, Bożena Bartkowiak-Dziankowska, Tomasz Durko

Published in: Rheumatology International | Issue 11/2011

Login to get access

Abstract

In systemic sclerosis (SSc), there may develop hearing and balance disorders as a result of the immune-mediated vasculitis and fibrosis in the inner ear. The objective of the study was evaluation of the hearing organ function in patients with SSc with relationship to duration of the disease and Raynaud phenomenon and also to type and severity of the disease. Twenty unselected, consecutive patients with SSc diagnosed in compliance with the international diagnostic criteria of the American Rheumatism Association (1982), were enrolled into the study. The control group consisted of 26 otologically healthy persons matched to the SSc group for age and sex. Case history was recorded for all patients from questionnaire data. Otolaryngological examination and battery of audiological tests (pure tone audiometry, speech audiometry, impedance audiometry and auditory brainstem response—ABR) were performed. In the anamnesis 60% of patients reported vertigo, 55% headaches, 50% tinnitus, 40% hyperacusis, 40% hearing loss and 30% ear fullness. It was found that patients with SSc had significantly poorer mean hearing thresholds than the control group for 0.5, 1, 6 and 8 kHz. In ABR there were no differences between SSc and control groups although an increase of latency averages in the group of limited patients with SSc compared with the diffuse patients with SSc was observed. In eight patients (40%) sensorineural hearing loss, mostly bilateral and symmetrical was found. Furthermore, no relation was seen between hearing level and duration, type and severity of the disease. Ear involvement is frequent in systemic sclerosis and should be taken into consideration during diagnostic and therapeutic procedures.
Literature
1.
go back to reference Barnett AJ (1996) History of scleroderma. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 3–22 Barnett AJ (1996) History of scleroderma. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 3–22
2.
go back to reference Fimiani C (2001) Systemic sclerosis: a woman disease. Mod Asp Immunobiol 1:233–237 Fimiani C (2001) Systemic sclerosis: a woman disease. Mod Asp Immunobiol 1:233–237
3.
go back to reference Braun-Falco O, Plewig G, Wolff HH, Burgdorf WH (2000) Dermatology, 2nd edn. Springer, Berlin, Heidelberg, New York Braun-Falco O, Plewig G, Wolff HH, Burgdorf WH (2000) Dermatology, 2nd edn. Springer, Berlin, Heidelberg, New York
4.
go back to reference Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef
5.
go back to reference Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity index. Ann Rheum Dis 60:592–598PubMedCrossRef Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity index. Ann Rheum Dis 60:592–598PubMedCrossRef
6.
go back to reference Rowell NR, Goodfield MJ (1998) The connective tissue diseases. In: Champion RH, Burton JL, Burns DA, Breathnach SM (eds) Rook/Wilkinson/Ebling textbook of dermatology, 6th edn. Blackwell, Boston, pp 2437–2452 Rowell NR, Goodfield MJ (1998) The connective tissue diseases. In: Champion RH, Burton JL, Burns DA, Breathnach SM (eds) Rook/Wilkinson/Ebling textbook of dermatology, 6th edn. Blackwell, Boston, pp 2437–2452
7.
go back to reference Clements PJ, Medsger TA Jr (1996) Organ involvement: skin. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 389–407 Clements PJ, Medsger TA Jr (1996) Organ involvement: skin. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 389–407
8.
go back to reference Rodnan GP, Lipiński E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22:130–140PubMedCrossRef Rodnan GP, Lipiński E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22:130–140PubMedCrossRef
9.
go back to reference Ruckenstein MJ (2004) Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 12:426–430PubMedCrossRef Ruckenstein MJ (2004) Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 12:426–430PubMedCrossRef
10.
go back to reference Mathews J, Rao S, Kumar BN (2003) Autoimmune sensorineural hearing loss: is it still a clinical diagnosis? J Laryngol Otol 117:212–214PubMedCrossRef Mathews J, Rao S, Kumar BN (2003) Autoimmune sensorineural hearing loss: is it still a clinical diagnosis? J Laryngol Otol 117:212–214PubMedCrossRef
11.
go back to reference Karatas E, Onat AM, Durucu C, Baglam T, Kanlikama M, Altunoren O, Buyukhatipoglu H (2007) Audiovestibular disturbance in patients with systemic lupus erythematosus. Otolaryngol Head Neck Surg 136:82–86PubMedCrossRef Karatas E, Onat AM, Durucu C, Baglam T, Kanlikama M, Altunoren O, Buyukhatipoglu H (2007) Audiovestibular disturbance in patients with systemic lupus erythematosus. Otolaryngol Head Neck Surg 136:82–86PubMedCrossRef
12.
go back to reference Kastanioudakis I, Skevas A, Danielidis V, Tsiakou E, Drosos AA, Moustopoulos MH (1995) Inner ear involvement in rheumatoid arthritis: a prospective clinical study. J Laryngol Otol 109:713–718PubMedCrossRef Kastanioudakis I, Skevas A, Danielidis V, Tsiakou E, Drosos AA, Moustopoulos MH (1995) Inner ear involvement in rheumatoid arthritis: a prospective clinical study. J Laryngol Otol 109:713–718PubMedCrossRef
13.
go back to reference Tumiati B, Casoli P, Parmeggiani A (1997) Hearing loss in the Sjögren syndrome. Ann Intern Med 126:450–453PubMed Tumiati B, Casoli P, Parmeggiani A (1997) Hearing loss in the Sjögren syndrome. Ann Intern Med 126:450–453PubMed
14.
go back to reference Wiles NM, Hunt BJ, Callanan V, Chevretton EB (2006) Sudden sensorineural hearing loss and antiphospholipid syndrome. Haematologica 91, 12 suppl: ECR 46 Wiles NM, Hunt BJ, Callanan V, Chevretton EB (2006) Sudden sensorineural hearing loss and antiphospholipid syndrome. Haematologica 91, 12 suppl: ECR 46
15.
go back to reference Alatas N, Yazgan P, Oztürk A, San I, Iynen I (2005) Audiological findings in patients with ankylosing spondylitis. J Laryngol Otol 119:534–549PubMedCrossRef Alatas N, Yazgan P, Oztürk A, San I, Iynen I (2005) Audiological findings in patients with ankylosing spondylitis. J Laryngol Otol 119:534–549PubMedCrossRef
16.
go back to reference Berretini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, Segnini G (1994) Audiovestibular involvement in systemic sclerosis. ORL J Otorhinolaryngol Relat Spec 56:195–198CrossRef Berretini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, Segnini G (1994) Audiovestibular involvement in systemic sclerosis. ORL J Otorhinolaryngol Relat Spec 56:195–198CrossRef
17.
go back to reference Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drodos AA, Skevas A (2001) Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg 124:522–525PubMedCrossRef Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drodos AA, Skevas A (2001) Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg 124:522–525PubMedCrossRef
18.
go back to reference Amor-Dorado J, Arias-Nuňez MC, Miranda-Filloy JA, Gonzales-Junatey C, Llorca J (2008) Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine 87:131–141PubMedCrossRef Amor-Dorado J, Arias-Nuňez MC, Miranda-Filloy JA, Gonzales-Junatey C, Llorca J (2008) Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine 87:131–141PubMedCrossRef
19.
go back to reference Tosti A, Patrizi A, Veronesi S (1984) Audiologic involvement in systemic sclerosis. Dermatologica 168:206PubMedCrossRef Tosti A, Patrizi A, Veronesi S (1984) Audiologic involvement in systemic sclerosis. Dermatologica 168:206PubMedCrossRef
20.
go back to reference Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Arthritis Rheum 23:581–590 Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Arthritis Rheum 23:581–590
21.
go back to reference Spoor A (1967) Presbyacusis values in relation to noise-induced hearing loss. Int Audiol 6:48–57CrossRef Spoor A (1967) Presbyacusis values in relation to noise-induced hearing loss. Int Audiol 6:48–57CrossRef
22.
go back to reference Gierek T (1979) Assessment of perception ability of the hearing organ in the 250 to 20.000 Hz range during the aging process of the human organism. Otolaryngol Pol 33:95–104PubMed Gierek T (1979) Assessment of perception ability of the hearing organ in the 250 to 20.000 Hz range during the aging process of the human organism. Otolaryngol Pol 33:95–104PubMed
23.
go back to reference Iskandar SB, Loyd S, Roy TM (2004) Cranial nerve VIII involvement in a patient with progressive systemic sclerosis. Tenn Med 97:117–119PubMed Iskandar SB, Loyd S, Roy TM (2004) Cranial nerve VIII involvement in a patient with progressive systemic sclerosis. Tenn Med 97:117–119PubMed
24.
go back to reference Santarelli R, Scimemi P, Dal Monte E, Genovese E, Arslan E (2006) Auditory neuropathy in systemic sclerosis: a speech perception and evoked potential study before and after cochlear implantation. Eur Arch Otorhinolaryngol 263:809–815PubMedCrossRef Santarelli R, Scimemi P, Dal Monte E, Genovese E, Arslan E (2006) Auditory neuropathy in systemic sclerosis: a speech perception and evoked potential study before and after cochlear implantation. Eur Arch Otorhinolaryngol 263:809–815PubMedCrossRef
25.
go back to reference Teasdal RD, Frayha RA, Shulman LE (1980) Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore) 59:149–159 Teasdal RD, Frayha RA, Shulman LE (1980) Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore) 59:149–159
26.
go back to reference Abou-Taleb A, Linthium FH (1987) Scleroderma and hearing loss: histopathology of case. J Laryngol Otol 10:656–662 Abou-Taleb A, Linthium FH (1987) Scleroderma and hearing loss: histopathology of case. J Laryngol Otol 10:656–662
27.
go back to reference Shah RK, Blevins NH, Karmody CS (2005) Mid-frequency sensorineural hearing loss: aetiology and prognosis. J Laryngol Otol 119:529–533PubMedCrossRef Shah RK, Blevins NH, Karmody CS (2005) Mid-frequency sensorineural hearing loss: aetiology and prognosis. J Laryngol Otol 119:529–533PubMedCrossRef
Metadata
Title
Hearing organ disorders in patients with systemic sclerosis
Authors
Katarzyna Maciaszczyk
Elżbieta Waszczykowska
Anna Pajor
Bożena Bartkowiak-Dziankowska
Tomasz Durko
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1503-5

Other articles of this Issue 11/2011

Rheumatology International 11/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine